Effects of the porcupine inhibitor, LGK974, on RNF43 mutant and wild type colorectal cancer cell lines

被引:0
|
作者
Bond, C. [1 ]
Kalimutho, M. [2 ]
Bettington, M. [1 ,3 ,4 ]
Pearson, S. [1 ]
Leggett, B. [1 ,4 ,5 ]
Whitehall, V. [1 ,4 ,6 ]
机构
[1] QIMR Berghofer Med Res Inst, Conjoint Gastroenterol Lab, Brisbane, Qld, Australia
[2] QIMR Berghofer Med Res Inst, Signal Transduct Lab, Brisbane, Qld, Australia
[3] Envoi Specialist Pathologists, Brisbane, Qld, Australia
[4] Univ Queensland, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia
[6] Pathol Queensland, Brisbane, Qld, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:73 / 73
页数:1
相关论文
共 50 条
  • [1] Porcupine Inhibitor LGK974 Downregulates the Wnt Signaling Pathway and Inhibits Clear Cell Renal Cell Carcinoma
    Li, Jianyi
    Wu, Guangzhen
    Xu, Yingkun
    Li, Jiatong
    Ruan, Ningke
    Chen, Yougen
    Zhang, Qi
    Xia, Qinghua
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [2] Evaluation of antitumor effects of aspirin and LGK974 drugs on cellular signaling pathways, cell cycle and apoptosis in colorectal cancer cell lines compared to oxaliplatin drug
    Bagheri, Malihe
    Far, Mohamad Amin Tabatabae
    Mirzaei, Hamed
    Ghasemi, Faezeh
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (01) : 51 - 64
  • [3] RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer
    Shang, Peipei
    Lu, Jiongjiong
    Song, Feihong
    Zhao, Yijun
    Hong, Weipeng
    He, Yuange
    Shen, Weidong
    Geng, Li
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia
    Koo, Bon-Kyoung
    van Es, Johan H.
    van den Born, Maaike
    Clevers, Hans
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (24) : 7548 - 7550
  • [5] Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family
    James M. Chan
    Mark Clendenning
    Sharelle Joseland
    Peter Georgeson
    Khalid Mahmood
    Jihoon E. Joo
    Romy Walker
    Julia Como
    Susan Preston
    Shuyi Marci Chai
    Yen Lin Chu
    Aaron L. Meyers
    Bernard J. Pope
    David Duggan
    J. Lynn Fink
    Finlay A. Macrae
    Christophe Rosty
    Ingrid M. Winship
    Mark A. Jenkins
    Daniel D. Buchanan
    Familial Cancer, 2024, 23 : 9 - 21
  • [6] Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family
    Chan, James M.
    Clendenning, Mark
    Joseland, Sharelle
    Georgeson, Peter
    Mahmood, Khalid
    Joo, Jihoon E.
    Walker, Romy
    Como, Julia
    Preston, Susan
    Chai, Shuyi Marci
    Chu, Yen Lin
    Meyers, Aaron L.
    Pope, Bernard J.
    Duggan, David
    Fink, J. Lynn
    Macrae, Finlay A.
    Rosty, Christophe
    Winship, Ingrid M.
    Jenkins, Mark A.
    Buchanan, Daniel D.
    FAMILIAL CANCER, 2024, 23 (01) : 9 - 21
  • [7] Identification of an RNF43 mutated gastric cancer patient population with potential sensitivity to porcupine inhibitor RXC004 and development of a complimentary ctDNA liquid biopsy assay for patient screening
    Bingham, M.
    Bhamra, I.
    Armer, R.
    Thompson, B.
    Woodcock, S.
    Thomason, A.
    Phillips, C.
    McKeever, H.
    Bradford, J.
    Chaffey, B.
    Little, L.
    Clack, G.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Porcupine inhibitor LGK-974 inhibits Wnt/β-catenin signaling and modifies tumor-associated macrophages resulting in inhibition of the malignant behaviors of non-small cell lung cancer cells
    Tang, Yang
    Jiang, Maoyan
    Chen, Anping
    Qu, Wendong
    Han, Xu
    Zuo, Jiebin
    Xu, Gang
    Song, Yongxiang
    Chen, Cheng
    Ke, Xixian
    MOLECULAR MEDICINE REPORTS, 2021, 24 (02)
  • [9] RNF43 p. G659fs mutation in MSI-high colorectal cancer leads to natural killer cell dysfunction
    De Silva, Pushpamali
    Fitzgerald, Samantha
    Cazaubiel, Jules
    Hofree, Matan
    Ugai, Tomotaka
    Vayrynen, Juha P.
    Ford-Roshon, Dane
    Fang, Lishan
    Garrido-Castro, Ana
    Hacohen, Nir
    Ng, Kimmie
    Ogino, Shuji
    Nowak, Jonathan A.
    Giannakis, Marios
    CANCER IMMUNOLOGY RESEARCH, 2024, 12 (10)
  • [10] ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY OF CETUXIMAB AGAINST COLORECTAL CANCER CELL LINES WITH WILD-TYPE AND MUTANT KRAS
    Nakadate, Y.
    Kitamura, Y.
    Tamura, T.
    Koizumi, F.
    ANNALS OF ONCOLOGY, 2012, 23 : 118 - 118